Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate CancerMetastatic Castration-resistant Prostate Neoplasms; Metastatic Hormone-sensitive Prostate CancerRecruitingPhase 12026-09-25NCT05818683

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Janssen Research & Development, LLC188

15 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Florida Cancer SpecialistsSarasotaUnited States47
Hosp Univ Fund Jimenez DiazMadridSpain33
Hosp Univ Hm SanchinarroMadridSpain17
Hosp Univ Vall D HebronBarcelonaSpain14
Hosp. Univ. 12 de OctubreMadridSpain68
Icon Cancer Centre Kurralta ParkKurralta ParkAustralia5
Laura & Isaac Perlmutter Cancer Center at NYU Langone Hospital - Long IslandMineolaUnited States5
Macquarie UniversityMacquarie UniversityAustralia3
NYU Langone HealthNew YorkUnited States403
Perlmutter Cancer Center at NYU Langone BrooklynBrooklynUnited States1
Peter MacCallum Cancer CentreMelbourneAustralia32
Princess Alexandra HospitalWoolloongabbaAustralia27
Sidney Kimmel Cancer Center - Jefferson HealthPhiladelphiaUnited States3
START MidwestGrand RapidsUnited States79
Washington University School of MedicineSt LouisUnited States895